A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LOXO-305) and Different Formulations of Midazolam in Healthy Participants
Clinical trial NCT06180967 · COMPLETED
Trial details
- NCT number
- NCT06180967
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-03
- Primary completion
- 2020-10-20
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.